Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_assertion type Assertion NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_head.
- NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_assertion description "[The sensitivity and specificity of MDM2 and CDK4 immunostainings in identifying ALT-WDLPS/DDLPS among other soft tissue tumors were 97% and 92%, and 83% and 95%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_provenance.
- NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_assertion evidence source_evidence_literature NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_provenance.
- NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_assertion SIO_000772 16160477 NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_provenance.
- NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_assertion wasDerivedFrom befree-20140225 NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_provenance.
- NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_assertion wasGeneratedBy ECO_0000203 NP810806.RAXr5OBZv4ecSzdgajwGCjw3OcgNWuGs3Ix-o8IETTlsQ130_provenance.